IRTC Stock Analysis: Buy, Sell, or Hold?

IRTC - iRhythm Technologies, Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$128.52
0.54 (0.42%) ▲
5d: +1.65%
30d: +19.36%
90d: +9.04%
WAIT
LOW Confidence
Protect Your IRTC Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026 0d

Get Alerted When IRTC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: IRTC shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$58.11
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$36.08
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: IRTC is currently trading at $128.52, which is considered extended relative to its 30-day fair value range of $112.36 to $126.53. From a valuation perspective, the stock is trading at a discount (Forward PE: 107.7) compared to its historical average (124.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, IRTC is showing sideways momentum. The price is approaching resistance at $129.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $176.86 (+37.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $112.36 - $126.53
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 60.4%

Protect Your Profits

Holding IRTC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (57/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 37.6% below Wall St target ($176.86)
  • WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $112.36 - $126.53
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$7.94 (6.2%)

Support & Resistance Levels

Support Level $114.95
Resistance Level $129.66
Current Trend Sideways
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 107.67
Wall Street Target $176.86 (+37.6%)
Revenue Growth (YoY) 20.1%
Profit Margin -1.7%
Valuation Discount vs History -4.7% cheaper
PE vs Historical 107.7 vs 124.4 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -4.7% (market-implied from PE analysis)
1-Year Target $122.48 (-5%)
2-Year Target $116.72 (-9%)
3-Year Target $111.24 (-13%)
3-Yr Target (if PE normalizes) (PE: 108→124) $128.52 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 107.7, Growth: 104.1%) $433.75 (+238%)
Base: (SPY PE: 20.1, Growth: 104.1%) $80.85 (-37%)
Bear: (PE: 17.1, Growth: 104.1%) $68.72 (-47%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 107.7 to 124.4
Stabilization Target: $148.48 (+15.5%)
PE Expansion Potential: +15.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 24, 2026 4:34 AM ET
Data refreshes hourly during market hours. Next update: 5:34 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Marc Wade Rosenbaum SELL 816 shares 2026-03-02
Chad Patterson SELL 4444 shares 2026-03-02
Sumi Shrishrimal SELL 2830 shares 2026-03-02

Unlock Insider Activity

See real-time buying/selling by company executives for IRTC.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$63 49 HOLD
SYK
Stryker Corporation
BUY
32 analysts
$383 53 HOLD
PODD
Insulet Corporation
STRONG BUY
24 analysts
$172 48 HOLD
DXCM
DexCom Inc
STRONG BUY
27 analysts
$94 31 SELL
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$120 37 SELL

Advanced IRTC Option Strategies

Professional options setups generated by AI based on today's IRTC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for IRTC

IRTC Technical Chart IRTC Price Prediction IRTC Earnings Date IRTC Investment Advisor IRTC Fair Price Analyzer IRTC Options Advisor IRTC Options Chain IRTC Options Analysis IRTC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals